Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
OtherTechnology/Application

Best Practices for Microbial Challenge In–use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations

Camellia Zamiri, Danielle L. Leiske, Patricia F. Hughes, J. Paul Kirwan, Evelyn Der, Emily Cox, Rob Warburton, Monica Goss, Sarah Weiser, Janet Perez-Brown, Ganapathy Gopalrathnam, Jing Liu, Shyam B. Mehta, Shebeer Shereefa, Sebastian Specht, Sandra J. Aedo, Pierre Goldbach, Feng Jia, Barbara Kuehnle, Scott Page, Liesbeth Voeten, Li Yi and Chen Zhu
PDA Journal of Pharmaceutical Science and Technology October 2023, pdajpst.2022.012806; DOI: https://doi.org/10.5731/pdajpst.2022.012806
Camellia Zamiri
1 Pharmaceutical Development, Genentech (A Member of the Roche group), 1 DNA Way, South San Francisco, CA 94080, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zamiri.camellia@gene.com
Danielle L. Leiske
2 Product Quality Management, Seagen, 21717 30th Drive S.E. Bothell, WA 98021, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: danielle.leiske@abcellera.com
Patricia F. Hughes
3 Office of Pharmaceutical Manufacturing Assessment, Office of Product Quality FDA/CDER, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: patricia.hughes@fda.hhs.gov
J. Paul Kirwan
4 Global Regulatory Affairs and Strategy, CMC, Amgen, One Amgen Center Dr, Thousand Oaks, CA 91320, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jkirwan@amgen.com
Evelyn Der
5 PTQP Analytical Sciences Chapter, Genentech (A Member of the Roche group), 1 DNA Way, South San Francisco, CA 94080, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: eder@gene.com
Emily Cox
6 BioPharmaceuticals Development, R&D, Dosage Form Design and Development, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: emily.cox1@astrazeneca.com
Rob Warburton
7 Bioproduct Research & Development, Eli Lilly & Company, Lilly Research Laboratories Eli Lilly and Company, Indianapolis, IN 46285, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: warburton_robert_e@lilly.com
Monica Goss
8 Drug Product Technologies, Amgen, One Amgen Center Dr, Thousand Oaks, CA 91320, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: monicap@amgen.com
Sarah Weiser
9 BTx PharmSci, Pharmaceutical Research and Development, Pfizer; 1 Burtt Rd, Andover, MA 01810, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sarah.weiser@pfizer.com
Janet Perez-Brown
10 Microbiology Center of Excellence, BMS, One Squibb Drive New Brunswick, NJ 08903, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: janet.perezbrown@bms.com
Ganapathy Gopalrathnam
11 Bioproduct Pharma Design, Eli Lilly & Company, Lilly Research Laboratories, Eli Lilly and Company Indianapolis, IN 46285 USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gopalrathnam_ganapathy@lilly.com
Jing Liu
12 Pharmaceutical Sciences, Seagen, 21717 30th Drive S.E. Bothell, WA 98021, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jliu@seagen.com
Shyam B. Mehta
13 Drug Product Development and Operations, CMC Biologics Teva Branded Pharmaceutical Products, 145 Brandywine Pkwy, West Chester, PA 19380 USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shyam.mehta02@tevapharm.com
Shebeer Shereefa
14 Regulatory Affairs CMC, AbbVie,1 N Waukegan Rd, North Chicago, IL 60064, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shebeer.shereefa@abbvie.com
Sebastian Specht
15 Regulatory Affairs, CMC, Roche, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sebastian.specht@roche.com
Sandra J. Aedo
16 BioTherapeutics Drug Product Development Janssen, Pharmaceutical Companies of Johnson & Johnson, Janssen Research and Development, Malvern, PA 19355, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: saedoalm@its.jnj.com
Pierre Goldbach
17 Pharmaceutical Development & Supplies, Pharma Technical Development, Roche, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pierre.goldbach@roche.com
Feng Jia
18 Biologics Drug Product, Biogen, 225 Binney Street, Cambridge, MA 02142, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: feng.jia@biogen.com
Barbara Kuehnle
19 Pharmaceutical Development, BI, Boehringer Ingelheim Pharma GmbH & Co. KG;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: barbara.kuehnle@boehringer-ingelheim.com
Scott Page
14 Regulatory Affairs CMC, AbbVie,1 N Waukegan Rd, North Chicago, IL 60064, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: scott.page@abbvie.com
Liesbeth Voeten
20 Analytical Development, Microbiology Center of Excellence Janssen, Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lvoeten@its.jnj.com
Li Yi
21 Formulation Development, AbbVie, 1000 Gateway Blvd, South San Francisco, CA 94080, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: li.yi@abbvie.com
Chen Zhu
22 Biologics Drug Product Development and Manufacturing, Sanofi, One the Mountain Road, Framingham, MA, 01701, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chen.zhu2@sanofi.com
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

pdajpst.2022.012806
DOI 
https://doi.org/10.5731/pdajpst.2022.012806
PubMed 
37848203

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received November 1, 2022
  • Accepted September 25, 2023
  • Published online October 25, 2023.

Article Versions

  • previous version (October 17, 2023 - 05:56).
  • You are currently viewing a previous version of this article (October 25, 2023 - 08:41).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2023, Parenteral Drug Association

Author Information

  1. Camellia Zamiri1,23 (zamiri.camellia{at}gene.com),
  2. Danielle L. Leiske2 (danielle.leiske{at}abcellera.com),
  3. Patricia F. Hughes3 (patricia.hughes{at}fda.hhs.gov),
  4. J. Paul Kirwan4 (jkirwan{at}amgen.com),
  5. Evelyn Der5 (eder{at}gene.com),
  6. Emily Cox6 (emily.cox1{at}astrazeneca.com),
  7. Rob Warburton7 (warburton_robert_e{at}lilly.com),
  8. Monica Goss8 (monicap{at}amgen.com),
  9. Sarah Weiser9 (sarah.weiser{at}pfizer.com),
  10. Janet Perez-Brown10 (janet.perezbrown{at}bms.com),
  11. Ganapathy Gopalrathnam11 (gopalrathnam_ganapathy{at}lilly.com),
  12. Jing Liu12 (jliu{at}seagen.com),
  13. Shyam B. Mehta13 (shyam.mehta02{at}tevapharm.com),
  14. Shebeer Shereefa14 (shebeer.shereefa{at}abbvie.com),
  15. Sebastian Specht15 (sebastian.specht{at}roche.com),
  16. Sandra J. Aedo16 (saedoalm{at}its.jnj.com),
  17. Pierre Goldbach17 (pierre.goldbach{at}roche.com),
  18. Feng Jia18 (feng.jia{at}biogen.com),
  19. Barbara Kuehnle19 (barbara.kuehnle{at}boehringer-ingelheim.com),
  20. Scott Page14 (scott.page{at}abbvie.com),
  21. Liesbeth Voeten20 (lvoeten{at}its.jnj.com),
  22. Li Yi21 (li.yi{at}abbvie.com) and
  23. Chen Zhu22 (chen.zhu2{at}sanofi.com)
  1. 1 Pharmaceutical Development, Genentech (A Member of the Roche group), 1 DNA Way, South San Francisco, CA 94080, USA;
  2. 2 Product Quality Management, Seagen, 21717 30th Drive S.E. Bothell, WA 98021, USA;
  3. 3 Office of Pharmaceutical Manufacturing Assessment, Office of Product Quality FDA/CDER, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA;
  4. 4 Global Regulatory Affairs and Strategy, CMC, Amgen, One Amgen Center Dr, Thousand Oaks, CA 91320, USA;
  5. 5 PTQP Analytical Sciences Chapter, Genentech (A Member of the Roche group), 1 DNA Way, South San Francisco, CA 94080, USA;
  6. 6 BioPharmaceuticals Development, R&D, Dosage Form Design and Development, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD, 20878, USA;
  7. 7 Bioproduct Research & Development, Eli Lilly & Company, Lilly Research Laboratories Eli Lilly and Company, Indianapolis, IN 46285, USA;
  8. 8 Drug Product Technologies, Amgen, One Amgen Center Dr, Thousand Oaks, CA 91320, USA;
  9. 9 BTx PharmSci, Pharmaceutical Research and Development, Pfizer; 1 Burtt Rd, Andover, MA 01810, USA;
  10. 10 Microbiology Center of Excellence, BMS, One Squibb Drive New Brunswick, NJ 08903, USA;
  11. 11 Bioproduct Pharma Design, Eli Lilly & Company, Lilly Research Laboratories, Eli Lilly and Company Indianapolis, IN 46285 USA;
  12. 12 Pharmaceutical Sciences, Seagen, 21717 30th Drive S.E. Bothell, WA 98021, USA;
  13. 13 Drug Product Development and Operations, CMC Biologics Teva Branded Pharmaceutical Products, 145 Brandywine Pkwy, West Chester, PA 19380 USA;
  14. 14 Regulatory Affairs CMC, AbbVie,1 N Waukegan Rd, North Chicago, IL 60064, USA;
  15. 15 Regulatory Affairs, CMC, Roche, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland;
  16. 16 BioTherapeutics Drug Product Development Janssen, Pharmaceutical Companies of Johnson & Johnson, Janssen Research and Development, Malvern, PA 19355, USA;
  17. 17 Pharmaceutical Development & Supplies, Pharma Technical Development, Roche, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland;
  18. 18 Biologics Drug Product, Biogen, 225 Binney Street, Cambridge, MA 02142, USA;
  19. 19 Pharmaceutical Development, BI, Boehringer Ingelheim Pharma GmbH & Co. KG;
  20. 20 Analytical Development, Microbiology Center of Excellence Janssen, Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium;
  21. 21 Formulation Development, AbbVie, 1000 Gateway Blvd, South San Francisco, CA 94080, USA;
  22. 22 Biologics Drug Product Development and Manufacturing, Sanofi, One the Mountain Road, Framingham, MA, 01701, USA
  1. ↵* Corresponding author; email: zamiri.camellia{at}gene.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Current Industry Best Practice on in-use Stability and Compatibility Studies for Biological Products
    Markus Blümel, Jing Liu, Isabella de Jong, Sarah Weiser, Jonas Fast, Jennifer Litowski, Melissa Shuman, Shyam B. Mehta, Leanne Amery, David Cheng Thiam Tan, Feng Jia, Dushyant Shekhawat, Camille Dagallier, Mina Emamzadeh, Annette Medina, Camilla Santos, Florian Gasser, Christian Urban
    Journal of Pharmaceutical Sciences 2023 112 9
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 79 (1)
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 1
January/February 2025
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Best Practices for Microbial Challenge In–use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Best Practices for Microbial Challenge In–use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
Camellia Zamiri, Danielle L. Leiske, Patricia F. Hughes, J. Paul Kirwan, Evelyn Der, Emily Cox, Rob Warburton, Monica Goss, Sarah Weiser, Janet Perez-Brown, Ganapathy Gopalrathnam, Jing Liu, Shyam B. Mehta, Shebeer Shereefa, Sebastian Specht, Sandra J. Aedo, Pierre Goldbach, Feng Jia, Barbara Kuehnle, Scott Page, Liesbeth Voeten, Li Yi, Chen Zhu
PDA Journal of Pharmaceutical Science and Technology Oct 2023, pdajpst.2022.012806; DOI: 10.5731/pdajpst.2022.012806

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Best Practices for Microbial Challenge In–use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
Camellia Zamiri, Danielle L. Leiske, Patricia F. Hughes, J. Paul Kirwan, Evelyn Der, Emily Cox, Rob Warburton, Monica Goss, Sarah Weiser, Janet Perez-Brown, Ganapathy Gopalrathnam, Jing Liu, Shyam B. Mehta, Shebeer Shereefa, Sebastian Specht, Sandra J. Aedo, Pierre Goldbach, Feng Jia, Barbara Kuehnle, Scott Page, Liesbeth Voeten, Li Yi, Chen Zhu
PDA Journal of Pharmaceutical Science and Technology Oct 2023, pdajpst.2022.012806; DOI: 10.5731/pdajpst.2022.012806
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Mechanical Container Closure Integrity Test: A Method for Cartridge Systems
  • Practical application of setting up an annual Contamination Control Strategy (CCS) assessment
  • A Container Closure Integrity Test Method for Vials Stored at Cryogenic Conditions Using Headspace Oxygen Analysis
Show more Technology/Application

Similar Articles

Keywords

  • Microbial challenge in-use studies
  • In-use hold
  • In-use storage
  • Microbial contamination
  • Microbial growth
  • Microbial stability

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire